For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Statement from the director-general of health Dr Ashley Bloomfield
Statement from the director-general of health Dr Ashley Bloomfield

In my earlier public statement, I stated that I attended the recent cricket match in a private capacity.
I was incorrect.
As I clarified earlier yesterday, I am in the role of the Director-General of Health every day.
I recognise that the invitation was extended to me because I am in that position. It is important that I avoid any potential for perception of a conflict of interest or personal benefit.
I thought I was acting within the Public Service Commission Guidelines on Chief Executive Gifts, Benefits and Expenses guidelines.
On re-reading the guidelines, I now accept that declaring the complimentary tickets to the game on a gift register was insufficient and that they should have been refused, as they will be from now on.
I have clarified this with the Public Service Commissioner.
I have donated the price of the tickets, and also the price of tickets to two Hurricanes games last year (also previously declared), to Wellington City Mission.